Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alza's First Steps As A FIBCO

Alza's first steps as a FIBCO

Without fanfare, Alza Corp. is quietly building a fully integrated company alongside its royalty-based research boutique.

AZA announced last week that it launched its Testoderm Testosterone Transdermal System, the first transdermal testosterone replacement for hypogonadal males.

Read the full 413 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers